- Research note
- Open access
- Published:
Development and optimizing a simple and cost-effective medium for in vitro culture of Plasmodium berghei-ANKA strain with conserving its infectivity in BALB/c mice
BMC Research Notes volume 15, Article number: 56 (2022)
Abstract
Objectives
The current culture system for P. berghei still requires modifications in consistency and long-term maintenance of parasites considering their pathogenicity in culture media. Therefore, this study designed to further improvement of culture conditions and designing a cost-effective culture medium with minimum changes in pathogenicity for in vitro culture of P. berghei.
Results
Results indicated that the rate of parasitaemia in our modified method remained statistically stable between days one to seven (P = 0.07). The current modified cultivation method was more efficient in maintaining of parasites for further days. Furthermore, in current method the stability of parasitaemia rate during day1 to day7 was in better rate compared to that in Ronan Jambou et al. and the differences between two methods were statistically significant (P = 0.001). The virulence of cultivated parasites in our modified method remained similar to frozen stock parasites as positive control group. No significant differences were seen in survival time between two groups of mice those were infected with either cultivated parasites or stock freeze parasites (P = 0.39) with the mean survival time of 20.83 ± 3.84 and 19.66 ± 1.21 days, respectively. Herein, we achieved a simple, cost-effective and applicable technique for culture of P. berghei.
Introduction
Malaria has been considered as a significant threat to health systems throughout the world for decades and presently, one third of the world's population are at risk of the infection [1, 2]. Global attempts to manage the disease, led to documented decrease in levels of morbidity and mortality due to malaria and nowadays the disease is approaching some levels of control worldwide [3, 4]. Plasmodium falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi are the most important causes of malaria, however, P. falciparum is considered as the deadliest species, accounting for an estimated 99.7% of malaria cases in Africa according to WHO report in 2018 [2, 5, 6]. Various procedures are conducted to control the malaria infection including diagnosis methods, treatment of patients, preparation of novel medications as well as control of vectors [7, 8]. One of the most important factors in performing control programs is to understand the biology of Plasmodium parasites in more details. However, the most imperative problem in conducting biological studies on malaria parasites is the cultivation and purification of the parasites [8]. Cultivating human malaria parasites (P. falciparum for instance) with gametocyte maturation stages, can lead to establishing of parasite cycle in nature if Anophel is available. Therefore, it is better to use non-human malaria parasites species but, phylogenetically close to human species in cultivation procedures [9, 10]. Plasmodium berghei is an African murine malaria parasite isolated by Vincke and Bafort in Katanga (PbNK for New York-Katanga) and in Kasapa (PbANKA for Antwerpen-Kasapa) and appropriate substitute model for studying Plasmodium species in both in vitro and in vivo investigations [11,12,13,14]. The first attempts were made to cultivate P. berghei on cell culture media conducted by Mons et al. in 1983 [15]. In vitro culture of P. berghei ANKA with maintaining infectivity of mouse erythrocytes inducing cerebral malaria described by Ronan Jambou et al. [11]. However, employing high quality culture media is expensive, sensitive and also due to variations in pathogenicity of parasites, cannot be used in pharmaceutical and similar studies. Moreover, the most notable issue in performing P. berghei cultivation is the necessity of completing several passages which may lead to a considerable reduction in pathogenicity of parasites and serious problems in biological studies, consequently [15, 16]. Therefore, the aim of the present study was to design a simple and cost-effective medium to maintain parasites for longer time with a mild rate of reduction during days and considering the changes in pathogenicity of cultivated parasites.
Main text
Methods
Mice
Thirty-four male BALB/c mice, with 6–8 weeks age and weighing 25 ± 5 g, were purchased from the Animal Breeding Stock Facility, Razi Vaccine and Serum Institute of Iran, Karaj, Iran (24 mice for in vivo experiments and 10 mice for parasite cultivation stages). Animals were kept under the standard laboratory environmental conditions (light–dark cycle conditions, controlled temperatures of 22 °C ± 2 °C) with ad libitum foods and fresh drinking tap water. The mice were maintained at the animal house section of School of Public Health, Tehran University of Medical Sciences according to the Standard Guidelines for the Care and Use of Laboratory Animals and the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) [17]. The sample size considering 10 percent attrition was calculated according to the previously described method [18]. The animal to be euthanized were first anaesthetized with ketamine (75 mg/kg) given subcutaneously. Finally, cervical dislocation was used on mice to ensure that they have been properly euthanized. All procedure were performed to avoid causing unnecessary pain to animals based on the rules of animal care and use research.
Compounds
DMEM-F12, RPMI 1640 (containing HEPES and glucose) media and heat-inactivated fetal calf serum (FCS) were purchased from Gibco, Germany. Gentamicin, NaOH, L-glutamine, Hypoxanthine, Gelatin, Calcium Bicarbonate, Hydroethidine were purchased from Sigma-Alderich, Germany. Albumax II was provided from Pasteur Institute of Iran. P. berghei ANKA (PbA) strain was obtained from National Laboratory of Malaria, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Maintenance of in vitro culture
In this study, the ANKA strain was originated from stock collections and then propagated in BALB/c mice via intra-peritoneally (IP) inoculation of 106 infected red blood cells (IRBCs) suspensions. Seven days after infection, when parasitaemia reached more than 10%, blood samples from infected mice were collected by cardiac puncture under the standard anaesthesia. All blood samples underwent the buffy coat removal process using routine phosphate buffered saline (PBS; pH = 7.4) washing method.
Maintenance of P. berghei using our modified technique
Starting this technique followed method described by Jensen and Trager [19] for Plasmodium falciparum cultivation with inspirations from protocol described by Ronan Janbou [11]. To prepare a complete culture medium (CCM), 500 mL RPMI 1640 medium (containing HEPES and glucose) supplemented with 10 mL NaOH 5 M, Hypoxanthine (0.027 gr dissolved in 5 mL DDW and 5µL NaOH 5 M),Gentamycin (0.025 gr dissolved in 2.5 mL DDW and 5µL NaOH) and 10% FBS. The cultivation was conducted in small petri-dishes those were placed in a candle jar and incubated at 34 °C in an incubator equipped with an orbital shaker (100 rpm) for 20 h. The media were daily centrifuged at 5000 g for 1 min and then suspended again with fresh medium and hematocrit was fixed at 10% using non-infected fresh red blood cells obtained from healthy mice. Fifty microliter of Albumax II was added every 3 days to culture media. At the next step, after successful cultivation of P. berghi with our modified method, we performed this method and method describe by Jambou et al., simultaneously [11].
Maintenance of P. berghei using Jambou et al. [11] technique
In this method culture media was comprised of RPMI1640 (containing HEPES, and L-Glutamine and Bicarbonate) (3/4), DMEM-F12 (1/4), Hypoxanthine 200 μM, Glucose 3 g/L, Gelatin 0.1%, Calcium 2 mM,,Choline 1 mM, Hydroethidine 200 μM and AlbuMAX II 0.5%. Culture media were stored at 32 °C and mice fresh and non-infected RBAs were added twice a week with the haematocrit rate at 2.5%. Culture flasks were kept closed in vertical position and gassed with a 5% O2, 5% CO2, and 90% N2 gas mixture with shaking at 100 rpm on an orbital shaker.
Microscopic examination
Monitoring of parasitemia and identification of the stage of the parasite in both techniques were carried out using thin blood smears staining with Giemsa stain following methanol fixation, and counting infected RBCs microscopically (Additional file 1: Figs. S1, S2). Rate of parasitemia was calculated by daily determination of the parasitaemia in culture, using thin blood Giemsa-stained smears. Parasites were counted on 100 fields at × 1000 magnification.
In vivo infectivity test
In vivo infectivity of the cultured parasites was evaluated by inoculating IRBCs in susceptible mice (BALB/c) using IP inoculation. The BALB/c mice were divided into 4 major groups including 6 mice in each group as follows: group 1 were infected with 106 IRBCs of frozen stock parasites as positive control group; group 2 were infected with 106 IRBCs but with those parasites that were cultivated in modified culture medium on the seventh days; group 3 received just PBS and group 4 remained uninfected as negative control group [20,21,22]. Mice of the first and second groups were bled from their tails one week after the infection, to evaluate the growth and mutilation of parasites. Moreover, in daily monitoring, the mortality rate was recorded for each group.
Statistical analysis
Statistical analysis was carried out using SPSS Software v.21 (IBM, Armonk, NY, USA). Statistical differences between groups were calculated using t-test with confidence intervals of 95%. Moreover, Kaplan–Meier method was used for comparison of the survival rates between the studied groups [23]. Data description was carried out by calculating frequencies and 95% confidence intervals. Differences were considered as significant when P ≤ 0.05. Results were reported as mean ± SD.
Results
In vitro experiments
Parasitaemia rate in our modified technique assessed for 17 days, in three petri-dishes (Table 1). In this method, the number of merozoites and IRBCs were increased up to day 8 and eventually the parasitaemia rate was decreased to < 0.1% on day 16 (Table 1). The results indicated that, the rate of parasitaemia in modified method was not statistically different during day1 to day7 (P = 0.078). The modified cultivation method was more efficient in maintaining of parasites and stability of parasitaemia rate during day1 to day7 compared to that in Jambou et al. technique. The differences between two methods were statistically significant (P = 0.001) (Table 2).
In vivo infectivity
The mean survival time of BALB/c mice in group 1 (inoculated with the freeze parasite) and group 2 (inoculated with parasite collected from the culture medium on the seventh day) include 19.66 ± 1.21 and 20.83 ± 3.84 days, respectively. All mice in group 1 died by day 21 but members of group 2 were survived by day 27. The third and fourth groups of non-infected mice were alive for up to 50 days (Fig. 1).
There was not any significant difference in survival time between group 1 and group 2 (P = 0.396). However, significant statically differences in survival time were observed among groups 1 and 2 against groups 3 and 4 (P = 0.001).
Discussion
In this study, a modified cultivating technique for malaria parasites which was an adoption protocol of P. falciparum in vitro cultivation, was employed to cultivate P. berghei. In fact, the method used in this study was a composition method of was P. berghei and P. falciparum cultivation procedures that were established years ago [11, 24]. Although, ethical standards recommend the use of in vitro culture methods as an alternative to in vivo studies Plasmodium parasites, except for P. falciparum, are hard-growing microorganisms in culture medium and despite numerous studies, their cultivation has not been completely achieved, especially in continuous cultivations [25]. Many attempts have been made to cultivate different types of Plasmodium, and so far some species of them have achieved considerable success to preserve them, more or less, for long time with in vitro conditions. However, more studies are still crucial to attain faster, uncomplicated and inexpensive cultivation [26,27,28].
There are various limitations in cultivating Plasmodium parasites and the most challenging problems are the sequestration of RBCs, the lack of non-infected cells for penetration of parasites and also short life span of RBCs in in vitro techniques [28,29,30]. Changing the temperature and adding RBCs on a daily basis in this study, resulted to higher parasitaemia compared to previous culture media. For instance, the rate of parasitaemia in the medium described by Jambou et al. [11] was decreased sharply to less than 0.5% by day 7 (P = 0.001), whenever, in present modified method, the rate of parasitaemia was not significantly decreased until day 7 (P = 0.078). Moreover, the composition of culture media in present study was simpler and except essential components in Plasmodium spp. cultivation, RPMI for example, we need less agents to enhance the culture media.
In vitro culture of P. falciparum was first described by Jensen and Trager [19], Janse [11] and Hollingdale [31]. Long-term in vitro cultivation of P. berghei was claimed to be obtained by Ramaiya et al. [32] at 27 °C, and by Smalley [33] who achieved a low multiplication rate at 15 °C. However, at 37 °C, a decrease in parasite density was always observed as a consequence of the instability of the RBC. In present study due to some modifications including composition of culture media, reducing the temperature, employing a shaker and increasing hemoglobin rate, we could keep the parasitemia in a high level in first 7 days of culture process. Considering the necessity of further investigations, the results of current study and its important approaches in in vitro cultivation can be beneficial in malaria researches such as genetics studies, molecular and cellular biology and vaccine development.
One of the most important drawbacks of culture method, is the reduction of pathogenicity in cultivated parasites after several passages which may lead to a serious problems in biological studies. In a study that was conducted by Weiss and Degiusti [16], P. berghei, which normally kills mice within three weeks of infection, has been modified in virulence via serial passage through tissue culture. The parasite lost 80% of its infectivity against mice in comparison with control stock parasites. Indeed, those P. berghei parasites that were cultivated in our modified technique could maintain their effective virulence up to 7 days against the BALB/c subjected mice.
Conclusions
In conclusion, this study shows that with a cost-effective culture medium and modified cultivation technique for P. berghei, accessing an applicable in vitro cultivation method with minimum changes in pathogenicity, is obtainable. Although all stages of human species of Plasmodium spp. have achieved different levels of success in cultivation methods, non-human species cultivation methods especially P. berghei and its erythrocytic stage has not changed significantly during recent years. Therefore, more investigations are needed to reach a reliable patent for alternation of Plasmodium species cultivation methods especially P. berghei for long-term culture procedures.
Limitations
In this study, parasitaemia rate in our modified technique assessed for 17 days, in three petri-dishes. Culture groups could be more and categorized for in vitro experiment. Moreover, comparing between methods could be performed in multiple times.
Availability of data and materials
All data generated or analyzed during this study are included in this published article. The raw data analyzed during the current study are publicly available via Figshare Repository (34).
Abbreviations
- WHO:
-
World Health Organization
- DMEM:
-
Dulbecco's Modified Eagle Medium
- RPMI:
-
Roswell Park Memorial Institute Medium
- FCS:
-
Fetal Calf Serum
- HEPES:
-
N-2-Hydroxyethylpiperazine-N'-2-Ethanesulfonic Acid
- IP:
-
Intra-Peritoneally
- IRBCs:
-
Infected Red Blood Cells
- PBS:
-
Phosphate Buffered Saline
References
Miller LH, Good MF, Milon G. Malaria pathogenesis. Science. 1994;264:1878–83.
World Health Organization. World Malaria Report 2019. Geneva: World Health Organization; 2019.
Ashley EA, Phyo AP, Woodrow CJ. Malaria. Lancet. 2018;391(10130):1608–21.
Noor AM, Kinyoki DK, Mundia CW, Kabaria CW, Mutua JW, Alegana VA, et al. The changing risk of Plasmodium falciparum malaria infection in Africa: 2000–10: a spatial and temporal analysis of transmission intensity. Lancet. 2014;383(9930):1739–47.
Qin L, Chen C, Chen L, Xue R, Ou-Yang M, Zhou C, et al. Worldwide malaria incidence and cancer mortality are inversely associated. Infect Agents Cancer. 2017;12(1):14.
Cibulskis RE, Alonso P, Aponte J, Aregawi M, Barrette A, Bergeron L, et al. Malaria: global progress 2000–2015 and future challenges. Infect Dis Poverty. 2016;5(1):1–8.
Zimmerman PA, Howes RE. Malaria diagnosis for malaria elimination. Curr Opin Infect Dis. 2015;28:446–54.
Wrighton KH. A novel vaccine target for malaria. Nat Rev Microbiol. 2020;18:361.
Rosa BG, Yang G-Z. Portable impedance analyzer as a rapid screening tool for Malaria: an experimental study with culture and blood infected samples by early forms of Plasmodium falciparum. IEEE Trans Biomed Eng. 2020;67(12):3531–41.
Jett C, Dia A, Cheeseman IH. Rapid emergence of clonal interference during malaria parasite cultivation. bioRxiv. 2020;7:41303.
Jambou R, El-Assaad F, Combes V, Grau GE. In vitro culture of Plasmodium berghei-ANKA maintains infectivity of mouse erythrocytes inducing cerebral malaria. Malar J. 2011;10(1):346.
Vincke I, Lips M. Un nouveau Plasmodium d’un rongeur sauvage du Congo, Plasmodium berghei n.sp. Ann Soc Belge Méd Trop. 1948;28:97–104.
Vincke LH, Bafort F. Results of 2 years of observation of the cyclical transmission of Plasmodium berghei. Ann Soc Belges Med Trop Parasitol Mycol. 1968;48:439–54.
Janse C, Mons B, Croon J, Van der Kaay H. Long-term in vitro cultures of Plasmodium berghei and preliminary observations on gametocytogenesis. Int J Parasitol. 1984;14(3):317–20.
Mons B, Janse C, Croon J, Van der Kaay H. In vitro culture of Plasmodium berghei using a new suspension system. Int J Parasitol. 1983;13(2):213–7.
Weiss ML, Degiusti DL. Modification of a malaria parasite (Plasmodium berghei) following passage through tissue culture. Nature. 1964;201(4920):731–2.
Goodman JR. The association for assessment and accreditation of laboratory animal care international fails to meaningfully address concerns regarding its accreditation program. J Appl Anim Welf Sci. 2015;18(3):314–5.
Arifin WN, Zahiruddin WM. Sample size calculation in animal studies using resource equation approach. Malays J Med Sci. 2017;24:101–5. https://doi.org/10.21315/mjms2017.24.5.11.
Jensen JB, Trager W. Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle jar method. J Parasitol. 1977;63(5):883–6.
Grau GE, Piguet PF, Engers HD, Louis JA, Vassalli P. Lambert PH:L3T4+ Tlymphocytes play a major role in the pathogenesis of murine cerebralmalaria. J Immunol. 1986;137:2348–54.
Shaw-Saliba K, Thomson-Luque R, Obaldía N III, Nuñez M, Dutary S, Lim C, et al. Insights into an optimization of Plasmodium vivax Sal-1 in vitro culture: the Aotus primate model. PLOS Negl Trop Dis. 2016;10(7):e0004870.
Teimouri A, Haghi AM, Nateghpour M, Farivar L, Hanifian H, Mavi SA, Zare R. Antimalarial efficacy of low molecular weight chitosan against Plasmodium berghei infection in mice. J Vector Borne Dis. 2016;53(4):312–6 (PMID: 28035107).
Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. 3rd ed. Baltimore: Williams and Wilkins; 1996.
Duffy S, Loganathan S, Holleran J, et al. Large-scale production of Plasmodium falciparum gametocytes for malaria drug discovery. Nat Protoc. 2016;11:976–92.
Guttes E, Guttes S, Rusch HP. Morphological observations on growth and differentiation of Physarum polycephalum grown in pure culture. Dev Biol. 1961;3(5):588–614.
Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65(3):418–20.
Haynes JD, Diggs CL, Hines FA, Desjardins RE. Culture of human malaria parasites Plasmodium falciparum. Nature. 1976;263(5580):767–9.
Lelievre J, Berry A, Benoit-Vical F. An alternative method for Plasmodium culture synchronization. Exp Parasitol. 2005;109(3):195–7.
Trigg P, Gutteridge W. A minimal medium for the growth of Plasmodium knowlesi in dilution cultures. Parasitology. 1971;62(1):113–23.
Trigg P, Shakespeare P. The effect of incubation in vitro on the susceptibility of monkey erythrocytes to invasion by Plasmodium knowlesi. Parasitology. 1976;73(2):149–60.
Hollingdale MR, Collins WE, Campbell CC, Schwartz AL. In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax. Am J Trop Med Hyg. 1985;34(2):216–22.
Ramaiya ML, Kamath VR, Renapurkar DM. Long-term in vitro cultivation of Plasmodium berghei. Int J Parasitol. 1987;17:1329–31.
Smalley ME, Butcher GA. The in vitro culture of the blood stages of Plasmodium berghei. Int J Parasitol. 1975;5:131–2.
Hanifian H, Nateghpour M, Motevalli Haghi A, et al. Development and optimizing a simple and cost-effective medium for in vitro culture of Plasmodium berghei-ANKA strain with conserving its infectivity in BALB/c mice. 2022. Figshare Repository, https://figshare.com/s/68f0f0d2f467680ee47e
Acknowledgements
We would like to acknowledge all staff from the National Malaria Laboratory (Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran) for their useful collaboration.
Funding
This research was financially supported by Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
HH and MN conceived, designed and performed the experiments, analyzed and interpreted the data, and wrote the original draft paper. AMH, AT, SR, and LF, contributed reagents, materials, analysis tools or data. HH and AT prepared the manuscript. MN and AT review and editing of the final version of manuscript. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was carried out according to the principles of the declaration of Helsinki. All parts of the current study were approved by Ethic Committee of Tehran University of Medical Sciences (Ethic ID: IR.TUMS.VCR.REC.1397.1071).
Consent for publication
Not applicable.
Competing interests
The authors declare that we do not have any competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1: Figure S1
. Monitoring parasitemia in culture of P. berghei via thin blood smears staining with Giemsa stain. Figure S2. Monitoring parasitemia in culture of P. berghei via thin blood smears staining with Giemsa stain.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Hanifian, H., Nateghpour, M., Motevalli Haghi, A. et al. Development and optimizing a simple and cost-effective medium for in vitro culture of Plasmodium berghei-ANKA strain with conserving its infectivity in BALB/c mice. BMC Res Notes 15, 56 (2022). https://doi.org/10.1186/s13104-022-05946-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13104-022-05946-z